• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国家族性乳腺监测指南发布 15 年后的零星实施情况。

Sporadic implementation of UK familial mammographic surveillance guidelines 15 years after original publication.

机构信息

Prevent Breast Cancer Centre, Wythenshawe Hospital Manchester Universities Foundation Trust, Wythenshawe, Manchester, M23 9LT, UK.

Genomic Medicine, Division of Evolution and Genomic Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester Universities Foundation Trust, St. Mary's Hospital, Oxford Road, Manchester, M13 9WL, UK.

出版信息

Br J Cancer. 2020 Feb;122(3):329-332. doi: 10.1038/s41416-019-0631-2. Epub 2019 Nov 25.

DOI:10.1038/s41416-019-0631-2
PMID:31761901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7000386/
Abstract

The National Institute of health and Care Excellence issued guidelines on familial breast cancer screening in 2004. Such guidelines should be uniformly implemented to ensure that members of the same family with the same level of risk, but living in different areas, have the same access to screening. We assessed uptake by creating a short, six question online survey designed to assess compliance in each regional area. We used this to conduct a survey of all 22 regional genetics services. There was a 100% response to the survey allowing a complete map to be created. The devolved nations had near complete compliance with the sole exception of SW Scotland, but in England the picture was fragmented with regions representing a combined population of 26.6 million (48%) not implementing the full NICE recommendations. Fifteen years after the publication of the original guidelines, major inequity in provision for screening still occurs and a postcode lottery exists for the management of women from families with a history of breast cancer. We estimate that up to 73 preventable breast cancer deaths occur each year due to the current inequity of access. It may be time to consider alternative funding and implementation models to ensure consistent access across the country.

摘要

2004 年,英国国家卫生与保健优化研究所发布了家族性乳腺癌筛查指南。这些指南应该得到统一实施,以确保具有相同风险水平、但居住在不同地区的同一家庭的成员能够获得相同的筛查机会。我们通过创建一个简短的六问题在线调查来评估参与情况,该调查旨在评估每个地区的遵守情况。我们对所有 22 个区域遗传服务进行了这项调查,调查得到了 100%的回复,从而可以创建一个完整的地图。除了苏格兰西南部,权力下放的国家几乎完全遵守了这些建议,但在英格兰,情况则较为分散,有 2660 万(占 48%)的地区没有完全实施英国国家卫生与保健优化研究所的全部建议。在最初的指南发布 15 年后,在提供筛查方面仍然存在重大不平等,而且对于有乳腺癌家族史的女性的管理,存在着邮政编码彩票现象。我们估计,由于目前获得机会的不平等,每年有多达 73 例可预防的乳腺癌死亡。现在可能是考虑替代资金和实施模式的时候了,以确保在全国范围内获得一致的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ab/7000386/317c9b473130/41416_2019_631_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ab/7000386/317c9b473130/41416_2019_631_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35ab/7000386/317c9b473130/41416_2019_631_Fig1_HTML.jpg

相似文献

1
Sporadic implementation of UK familial mammographic surveillance guidelines 15 years after original publication.英国家族性乳腺监测指南发布 15 年后的零星实施情况。
Br J Cancer. 2020 Feb;122(3):329-332. doi: 10.1038/s41416-019-0631-2. Epub 2019 Nov 25.
2
Nationwide cross-sectional adherence to mammography screening guidelines: national behavioral risk factor surveillance system survey results.全国范围内对乳腺钼靶筛查指南的依从性:国家行为危险因素监测系统调查结果。
Breast Cancer Res Treat. 2017 Aug;164(3):719-725. doi: 10.1007/s10549-017-4286-5. Epub 2017 May 15.
3
Impact of national guidelines on family history breast cancer surveillance.国家指南对乳腺癌家族史监测的影响。
Scott Med J. 2011 Nov;56(4):203-5. doi: 10.1258/smj.2011.011158.
4
Breast cancer detection among Irish BRCA1 & BRCA2 mutation carriers: a population-based study.爱尔兰BRCA1和BRCA2突变携带者中的乳腺癌检测:一项基于人群的研究。
Ir J Med Sci. 2016 Feb;185(1):189-94. doi: 10.1007/s11845-015-1267-8. Epub 2015 Feb 12.
5
Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.家族性乳腺癌风险女性的磁共振成像筛查的成本效益。
J Natl Cancer Inst. 2013 Sep 4;105(17):1314-21. doi: 10.1093/jnci/djt203. Epub 2013 Aug 12.
6
Physician adherence to U.S. Preventive Services Task Force mammography guidelines.医生对美国预防服务工作组乳腺 X 线摄影指南的依从性。
Womens Health Issues. 2014 May-Jun;24(3):e313-9. doi: 10.1016/j.whi.2014.03.003.
7
The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan.MRI 筛查 BRCA 突变携带者的临床影响:日本的首次报告。
Breast Cancer. 2019 Sep;26(5):552-561. doi: 10.1007/s12282-019-00955-6. Epub 2019 Feb 28.
8
Mammographic, US, and MR imaging phenotypes of familial breast cancer.家族性乳腺癌的乳腺X线摄影、超声及磁共振成像表现型
Radiology. 2008 Jan;246(1):58-70. doi: 10.1148/radiol.2461062173.
9
Usefulness of Canadian Public Health Insurance Administrative Databases to Assess Breast and Ovarian Cancer Screening Imaging Technologies for BRCA1/2 Mutation Carriers.利用加拿大公共医疗保险管理数据库评估BRCA1/2突变携带者的乳腺癌和卵巢癌筛查成像技术
Can Assoc Radiol J. 2016 Nov;67(4):308-312. doi: 10.1016/j.carj.2015.12.003. Epub 2016 Jun 16.
10
Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer.基于癌症的标准在乳腺癌患者主流 BRCA1 和 BRCA2 基因检测中的应用评估。
JAMA Netw Open. 2019 May 3;2(5):e194428. doi: 10.1001/jamanetworkopen.2019.4428.

引用本文的文献

1
Risk stratification in breast screening workshop.乳腺筛查中的风险分层研讨会
BMC Proc. 2024 Oct 24;18(Suppl 19):22. doi: 10.1186/s12919-024-00306-0.
2
Digital innovation for cancer risk assessment allows large-scale service redevelopment of regional cancer genetics service delivery.数字化创新用于癌症风险评估,使区域性癌症遗传学服务交付的大规模服务重新开发成为可能。
Fam Cancer. 2024 Nov;23(4):591-598. doi: 10.1007/s10689-024-00407-x. Epub 2024 Jul 1.
3
Proactive breast cancer risk assessment in primary care: a review based on the principles of screening.

本文引用的文献

1
Final Results of the Prospective FH02 Mammographic Surveillance Study of Women Aged 35-39 at Increased Familial Risk of Breast Cancer.乳腺癌家族风险增加的35-39岁女性前瞻性FH02乳腺钼靶筛查研究的最终结果
EClinicalMedicine. 2019 Jan;7:39-46. doi: 10.1016/j.eclinm.2019.01.005.
2
Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.乳腺癌筛查与诊断,2018 年第 3 版,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2018 Nov;16(11):1362-1389. doi: 10.6004/jnccn.2018.0083.
3
Assessment of the 2016 National Institute for Health and Care Excellence high-sensitivity troponin rule-out strategy.
初级保健中的主动乳腺癌风险评估:基于筛查原则的综述。
Br J Cancer. 2023 May;128(9):1636-1646. doi: 10.1038/s41416-023-02145-w. Epub 2023 Feb 3.
4
UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: , , and .英国癌症易感基因种系致病性变异女性癌症风险临床管理共识推荐:,, 和 。
J Med Genet. 2023 May;60(5):417-429. doi: 10.1136/jmg-2022-108898. Epub 2022 Nov 21.
5
Implementing Risk-Stratified Breast Screening in England: An Agenda Setting Meeting.在英国实施风险分层乳腺筛查:一次议程设定会议
Cancers (Basel). 2022 Sep 24;14(19):4636. doi: 10.3390/cancers14194636.
6
Proteinuria is a late-onset adverse event in patients treated with cabozantinib.蛋白尿是接受卡博替尼治疗的患者的一种迟发性不良事件。
J Endocrinol Invest. 2021 Jan;44(1):95-103. doi: 10.1007/s40618-020-01272-y. Epub 2020 May 3.
评估 2016 年国家卫生与保健卓越研究所高敏肌钙蛋白排除策略。
Heart. 2018 Apr;104(8):665-672. doi: 10.1136/heartjnl-2017-311983. Epub 2017 Sep 1.
4
Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention.国家乳腺癌筛查计划中年轻女性的乳腺癌风险:对应用英国国家卫生与临床优化研究所(NICE)额外筛查和化学预防指南的启示
Cancer Prev Res (Phila). 2014 Oct;7(10):993-1001. doi: 10.1158/1940-6207.CAPR-14-0037. Epub 2014 Jul 21.
5
Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.评估 40-49 岁有中度乳腺癌家族史的女性的乳腺 X 线摄影监测服务:单臂队列研究。
Health Technol Assess. 2013 Mar;17(11):vii-xiv, 1-95. doi: 10.3310/hta17110.
6
Breast MRI use uncommon among U.S. women.美国女性对乳房 MRI 的使用率较低。
Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):159-66. doi: 10.1158/1055-9965.EPI-12-0967. Epub 2012 Nov 15.
7
Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study.50 岁以下有乳腺癌家族史的女性进行乳房 X 线摄影监测:前瞻性、单臂 FH01 研究中的肿瘤特征和对死亡率的预计影响。
Lancet Oncol. 2010 Dec;11(12):1127-34. doi: 10.1016/S1470-2045(10)70263-1. Epub 2010 Nov 17.
8
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.美国癌症协会关于以MRI作为乳房X线摄影辅助手段进行乳房筛查的指南。
CA Cancer J Clin. 2007 Mar-Apr;57(2):75-89. doi: 10.3322/canjclin.57.2.75.
9
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).对英国乳腺癌家族风险高的人群进行磁共振成像和乳房X线摄影筛查:一项前瞻性多中心队列研究(MARIBS)
Lancet. 2005;365(9473):1769-78. doi: 10.1016/S0140-6736(05)66481-1.
10
Development of a protocol for evaluation of mammographic surveillance services in women under 50 with a family history of breast cancer.制定一项针对有乳腺癌家族史的50岁以下女性乳腺钼靶筛查服务评估方案。
J Epidemiol Biostat. 2001;6(5):365-9; discussion 371-5.